These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3012254)

  • 41. Arginine vasopressin and corticotropin releasing factor: binding to ovine anterior pituitary membranes.
    Shen PJ; Clarke IJ; Canny BJ; Funder JW; Smith AI
    Endocrinology; 1990 Nov; 127(5):2085-9. PubMed ID: 2226302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of interleukin-1 receptors in the brain-endocrine-immune axis by stress and infection.
    Takao T; Hashimoto K; De Souza EB
    Brain Behav Immun; 1995 Dec; 9(4):276-91. PubMed ID: 8903846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttranslational processing of corticotropin-releasing factor in the ovine tuberoinfundibular system and pituitary.
    Smith AI; Engler D; Fullerton MJ; Pham T; Wallace C; Morgan FJ; Clarke IJ; Funder JW
    Ann N Y Acad Sci; 1987; 512():24-47. PubMed ID: 3502065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary.
    Potter E; Sutton S; Donaldson C; Chen R; Perrin M; Lewis K; Sawchenko PE; Vale W
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8777-81. PubMed ID: 8090722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain receptors for hypothalamic hormones.
    Catt KJ; Millan MA; Wynn PC; Mendelsohn FA; Aguilera G
    Adv Biochem Psychopharmacol; 1987; 43():51-67. PubMed ID: 3035894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of a pituitary corticotropin-releasing factor binding protein by chemical cross-linking.
    Nishimura E; Billestrup N; Perrin M; Vale W
    J Biol Chem; 1987 Sep; 262(27):12893-6. PubMed ID: 2820956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand requirements of the human corticotropin-releasing factor-binding protein.
    Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
    Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical characterization of corticotrophin releasing factor receptor in rat pituitary and brain.
    Flores M; Carvallo P; Aguilera G
    Life Sci; 1990; 47(22):2035-40. PubMed ID: 2177129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.
    Vita N; Laurent P; Lefort S; Chalon P; Lelias JM; Kaghad M; Le Fur G; Caput D; Ferrara P
    FEBS Lett; 1993 Nov; 335(1):1-5. PubMed ID: 8243652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of corticotropin-releasing factor receptors in primate brain.
    Millan MA; Jacobowitz DM; Hauger RL; Catt KJ; Aguilera G
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1921-5. PubMed ID: 2869491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased corticotropin-releasing factor-like immunoreactivity in rat intermediate and posterior pituitary after stalk section.
    Saavedra JM; Rougeot C; Culman J; Israel A; Niwa M; Tonon MC; Vaudry H; Dray F
    Neuroendocrinology; 1984 Jul; 39(1):93-5. PubMed ID: 6611513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Characterization and modulation of anterior pituitary binding sites for rat corticotropin releasing factor (r-CRF)].
    Grino M; Castanas E; Conte-Devolx B; Guillaume V; Boudouresque F; Oliver C
    Ann Endocrinol (Paris); 1986; 47(1):51-3. PubMed ID: 3021045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.
    Van Pett K; Viau V; Bittencourt JC; Chan RK; Li HY; Arias C; Prins GS; Perrin M; Vale W; Sawchenko PE
    J Comp Neurol; 2000 Dec; 428(2):191-212. PubMed ID: 11064361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of corticotropin-releasing factor (CRF) and alpha-helical CRF on rat neurointermediate lobes: in vitro studies.
    Saland LC; Carr JA; Samora A; Benavidez S; Tejeda D
    Neuropeptides; 1991 Jul; 19(3):213-21. PubMed ID: 1896131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exposure to an antisense oligonucleotide decreases corticotropin-releasing factor receptor binding in rat pituitary cultures.
    Owens MJ; Mulchahey JJ; Kasckow JW; Plotsky PM; Nemeroff CB
    J Neurochem; 1995 May; 64(5):2358-61. PubMed ID: 7722522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.